SRTS
Sensus Healthcare Inc

1,173
Mkt Cap
$66.34M
Volume
31,453.00
52W High
$5.92
52W Low
$3.03
PE Ratio
-8.50
SRTS Fundamentals
Price
$4.02
Prev Close
$3.99
Open
$3.93
50D MA
$4.44
Beta
0.96
Avg. Volume
114,680.15
EPS (Annual)
-$0.4728
P/B
1.38
Rev/Employee
$508,925.93
$43.37
Loading...
Loading...
News
all
press releases
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·1d ago
News Placeholder
More News
News Placeholder
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·9d ago
News Placeholder
Wall Street Zen Downgrades Sensus Healthcare (NASDAQ:SRTS) to Sell
Wall Street Zen lowered shares of Sensus Healthcare from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·13d ago
News Placeholder
Sensus Healthcare Q4 Earnings Call Highlights
Sensus Healthcare (NASDAQ:SRTS) used its fourth-quarter and full-year 2025 earnings call to emphasize a major regulatory and reimbursement milestone that management believes reshapes the company's...
MarketBeat·14d ago
News Placeholder
Sensus Healthcare SRTS Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·15d ago
News Placeholder
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS
Sensus Healthcare (NASDAQ:SRTS - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.09) by...
MarketBeat·15d ago
News Placeholder
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·15d ago
News Placeholder
Preview: Sensus Healthcare's Earnings
read more...
Benzinga·16d ago
News Placeholder
Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Hold" from Brokerages
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) has been given an average recommendation of "Hold" by the five brokerages that are covering the company, MarketBeat Ratings reports. One...
MarketBeat·22d ago
News Placeholder
Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·22d ago
<
1
2
...
>

Latest SRTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.